Moving Towards Personalised Medicine with Big Data Strategies

  The use of Big Data strategies is thought to have the potential to help physicians and scientists move closer to treating individuals, rather than diseases. Developing treatments that are tailored to an individual’s history and sensitivities presents many challenges, and will only be possible within a digital health care system. An article from 20 January 2011 in the U.S. News & World …

Filling the Innovation Gap with Big Data

Data and information form the cornerstone of innovation, and it will take a change in mindset for the pharmaceutical industry to fill the innovation gap and change the way drug research is conducted. Drug approval has been flat for the last two decades, while the cost of drug development is constantly rising. Solid real world evidence of the drug performance …

Utilizing Global Pricing Data and Advanced Analytics for Better Decisions and Competitor Edge

By Preeti Patel, VP, Consulting Increasing price transparency and global competition are key challenges faced by companies across all industries. Today’s pricing decisions cannot be based on instinct or informal methods due to the high level of risk incurred through inaccurate practices. Data and analytics have become powerful tools for pharmaceutical organizations in their strive to stay ahead of competitors. …

Guest post: How often is PRO data being used in health technology assessments?

      *This post was originally posted on the Context Matters blog* Context Matters will be exhibiting at Health Technology Assessment World Europe this December in London.  Join us at the 6th annual policy forum for the industry where all the major HTA agencies across the world and leading pharmaceutical companies discuss the challenges in obtaining market access.   …